ATE231128T1 - Verbindungen mit kondensierten ringen, verfahren zu ihrer herstellung und ihre anwendung - Google Patents
Verbindungen mit kondensierten ringen, verfahren zu ihrer herstellung und ihre anwendungInfo
- Publication number
- ATE231128T1 ATE231128T1 AT98904386T AT98904386T ATE231128T1 AT E231128 T1 ATE231128 T1 AT E231128T1 AT 98904386 T AT98904386 T AT 98904386T AT 98904386 T AT98904386 T AT 98904386T AT E231128 T1 ATE231128 T1 AT E231128T1
- Authority
- AT
- Austria
- Prior art keywords
- substituted
- group
- joints
- production
- application
- Prior art date
Links
- 201000011510 cancer Diseases 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 206010027476 Metastases Diseases 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- 125000005678 ethenylene group Chemical group [H]C([*:1])=C([H])[*:2] 0.000 abstract 1
- 125000005677 ethinylene group Chemical group [*:2]C#C[*:1] 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000009401 metastasis Effects 0.000 abstract 1
- 125000001434 methanylylidene group Chemical group [H]C#[*] 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 150000003431 steroids Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
- C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Vaporization, Distillation, Condensation, Sublimation, And Cold Traps (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3792797 | 1997-02-21 | ||
| PCT/JP1998/000688 WO1998037070A1 (en) | 1997-02-21 | 1998-02-19 | Fused ring compounds, process for producing the same and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE231128T1 true ATE231128T1 (de) | 2003-02-15 |
Family
ID=12511197
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98904386T ATE231128T1 (de) | 1997-02-21 | 1998-02-19 | Verbindungen mit kondensierten ringen, verfahren zu ihrer herstellung und ihre anwendung |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US6420375B1 (de) |
| EP (1) | EP0974584B1 (de) |
| CN (1) | CN1251577A (de) |
| AT (1) | ATE231128T1 (de) |
| AU (1) | AU6229698A (de) |
| CA (1) | CA2281598A1 (de) |
| DE (1) | DE69810760T2 (de) |
| WO (1) | WO1998037070A1 (de) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW407153B (en) * | 1997-10-27 | 2000-10-01 | Nippon Kayaku Kk | Imidazole compounds and their use |
| EP1140858A2 (de) | 1998-12-23 | 2001-10-10 | AstraZeneca AB | Arylpropenylimidazole als farnesyl-proteintransferasehemmer |
| EP1147214B1 (de) | 1999-01-13 | 2011-01-05 | The Research Foundation Of State University Of New York | Neues verfahren zum erschaffen von proteinkinase-inhibitoren |
| US6417366B2 (en) * | 1999-06-24 | 2002-07-09 | Abbott Laboratories | Preparation of quinoline-substituted carbonate and carbamate derivatives |
| US6552078B2 (en) | 1999-10-27 | 2003-04-22 | Nobex Corp | 6-methoxy-2-naphthylacetic acid prodrugs |
| US6436990B1 (en) | 1999-10-27 | 2002-08-20 | Nobex Corporation | 6-methoxy-2-naphthylacetic acid prodrugs |
| TWI262791B (en) * | 1999-10-27 | 2006-10-01 | Nobex Corp | 6-methoxy-2-naphthylacetic acid prodrugs |
| CA2429133C (en) | 2000-11-17 | 2009-08-18 | Takeda Chemical Industries, Ltd. | Novel imidazole derivatives, production method thereof and use thereof |
| DE60144246D1 (de) | 2000-11-20 | 2011-04-28 | Takeda Pharmaceutical | Imidazolderivate, verfahren zu deren herstellung und deren verwendung |
| WO2002046186A1 (en) * | 2000-12-08 | 2002-06-13 | Takeda Chemical Industries, Ltd. | Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof |
| JP4623962B2 (ja) * | 2001-10-22 | 2011-02-02 | ザ・リサーチ・ファウンデーション・オブ・ステイト・ユニバーシティ・オブ・ニューヨーク | タンパク質キナーゼおよびホスファターゼ阻害剤、それらを設計する方法、ならびにそれらを使用する方法 |
| US7005445B2 (en) | 2001-10-22 | 2006-02-28 | The Research Foundation Of State University Of New York | Protein kinase and phosphatase inhibitors and methods for designing them |
| WO2003104178A1 (en) * | 2002-06-07 | 2003-12-18 | Cortical Pty Ltd | Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (mif) |
| US7838542B2 (en) | 2006-06-29 | 2010-11-23 | Kinex Pharmaceuticals, Llc | Bicyclic compositions and methods for modulating a kinase cascade |
| EP2330909B1 (de) * | 2008-08-12 | 2013-09-18 | GlaxoSmithKline LLC | Chemische verbindungen |
| JP5993742B2 (ja) | 2009-10-29 | 2016-09-14 | ジェノスコ | キナーゼ阻害剤 |
| WO2017138588A1 (ja) | 2016-02-10 | 2017-08-17 | 住友化学株式会社 | １－メチルピロリジン－３－オールの製造方法 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3642781A (en) * | 1968-10-15 | 1972-02-15 | Warner Lambert Co | Substituted acrylic acids and process for their production |
| US4237133A (en) * | 1977-11-14 | 1980-12-02 | Pfizer Inc. | 1,9-Dihydroxyoctahydrophenanthrenes |
| GB8417559D0 (en) * | 1984-07-10 | 1984-08-15 | Pfizer Ltd | Anti-diarrhoeal agents |
| LU86022A1 (fr) * | 1985-07-25 | 1987-02-04 | Cird | Derives aromatiques polycyliques,leur procede de preparation et leur application dans les domaines pharmaceutique et cosmetique |
| NZ221729A (en) * | 1986-09-15 | 1989-07-27 | Janssen Pharmaceutica Nv | Imidazolyl methyl-substituted benzimidazole derivatives and pharmaceutical compositions |
| JP2852659B2 (ja) * | 1988-03-03 | 1999-02-03 | 富山化学工業株式会社 | ピペラジン誘導体およびその塩 |
| JPH07121933B2 (ja) | 1988-03-28 | 1995-12-25 | キッセイ薬品工業株式会社 | ジヒドロベンゾフラノン誘導体 |
| US5273977A (en) * | 1990-11-05 | 1993-12-28 | Warner-Lambert Company | Substituted tetrahydropyridines and hydroxypiperidines as central nervous system agents |
| JP3157882B2 (ja) * | 1991-11-15 | 2001-04-16 | 帝国臓器製薬株式会社 | 新規なベンゾチオフエン誘導体 |
| GB9220735D0 (en) * | 1992-10-02 | 1992-11-18 | British Tech Group | Heterocyclic amines |
| JPH06239856A (ja) | 1993-02-15 | 1994-08-30 | Shin Nippon Yakuhin Kk | １，３−ベンゾオキサチオール−２−チオン誘導体 |
| JPH06293640A (ja) | 1993-02-15 | 1994-10-21 | Shin Nippon Yakuhin Kk | 肝疾患治療剤および１，３−ベンゾキサチオール誘導体 |
| GB9310635D0 (en) * | 1993-05-21 | 1993-07-07 | Glaxo Group Ltd | Chemical compounds |
| EP0721943A4 (de) * | 1993-09-30 | 1996-09-04 | Yamanouchi Pharma Co Ltd | Azol-derivate und pharmazeutische präparate |
| JPH07173120A (ja) | 1993-10-08 | 1995-07-11 | Banyu Pharmaceut Co Ltd | 置換芳香族カルボン酸誘導体 |
| JPH10512251A (ja) | 1995-01-10 | 1998-11-24 | スミスクライン・ビーチャム・ソシエタ・ペル・アチオニ | 骨粗鬆症の治療に有用なインドール誘導体 |
| WO1996023773A1 (en) | 1995-02-03 | 1996-08-08 | Banyu Pharmaceutical Co., Ltd. | 4-oxo-2-butenoic acid derivatives |
| WO1997017321A1 (fr) | 1995-11-07 | 1997-05-15 | Banyu Pharmaceuticals Co., Ltd. | Derives cycliques d'acide amique |
| CZ172498A3 (cs) * | 1995-12-06 | 1998-12-16 | Astra Pharmaceuticals Ltd. | Sloučenina |
| US6017919A (en) | 1996-02-06 | 2000-01-25 | Japan Tobacco Inc. | Compounds and pharmaceutical use thereof |
| FR2746098B1 (fr) | 1996-03-14 | 1998-04-30 | Composes propynyl biaromatiques | |
| CO4780021A1 (es) | 1996-03-29 | 1999-05-26 | Tanabe Seiyaku Co | Derivados de butadieno y procedimiento para la preparacion de los mismos |
| BR9710230A (pt) * | 1996-07-09 | 1999-08-10 | Smithkline Beecham Spa | Derivados de indol para o tratamento de osteoporose |
| US6005000A (en) * | 1996-08-22 | 1999-12-21 | Oxis International, Inc. | 5,5-Disubstituted-3, 4-dihydroxy-2(5H)-furanones and methods of use therefor |
-
1998
- 1998-02-19 CN CN98803784.XA patent/CN1251577A/zh active Pending
- 1998-02-19 CA CA002281598A patent/CA2281598A1/en not_active Abandoned
- 1998-02-19 US US09/367,896 patent/US6420375B1/en not_active Expired - Fee Related
- 1998-02-19 AU AU62296/98A patent/AU6229698A/en not_active Abandoned
- 1998-02-19 WO PCT/JP1998/000688 patent/WO1998037070A1/ja not_active Ceased
- 1998-02-19 DE DE69810760T patent/DE69810760T2/de not_active Expired - Fee Related
- 1998-02-19 EP EP98904386A patent/EP0974584B1/de not_active Expired - Lifetime
- 1998-02-19 AT AT98904386T patent/ATE231128T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69810760D1 (de) | 2003-02-20 |
| US6420375B1 (en) | 2002-07-16 |
| DE69810760T2 (de) | 2003-11-20 |
| EP0974584B1 (de) | 2003-01-15 |
| EP0974584A1 (de) | 2000-01-26 |
| AU6229698A (en) | 1998-09-09 |
| CA2281598A1 (en) | 1998-08-27 |
| CN1251577A (zh) | 2000-04-26 |
| WO1998037070A1 (en) | 1998-08-27 |
| EP0974584A4 (de) | 2000-05-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69810760D1 (de) | Verbindungen mit kondensierten ringen, verfahren zu ihrer herstellung und ihre anwendung | |
| ATE131470T1 (de) | Neue arylethenylenderivate und verfahren zu ihrer herstellung | |
| DE69532817D1 (de) | Verwendung von pyrazole verbindungen zur behandlung von glomerulonephritis, krebs, atherosklerose oder restenose | |
| ATE37375T1 (de) | Phosphonyl-hydroxyacyl-aminosaeure-derivate und ihre verwendung als antihypertensiva. | |
| DE69835877D1 (de) | Trizyklische verbindungen | |
| ATE264846T1 (de) | Substituierte benzimidazol-derivaten und ihre verwendung zur behandlung retroviraler infektionen | |
| ATE241625T1 (de) | Heterocyclische verbindungen, ihre herstellung und verwendung | |
| CA2236814A1 (en) | Quinoline and quinazoline compounds useful in therapy | |
| ATE173165T1 (de) | Zusammensetzung, verfahren und instrument zur potenzierung der antitumoraktivität und zur behandlung von tumoren | |
| ATE361748T1 (de) | 1-(4-sulfamylphenyl)-3-trifluormethyl-5-aryl-2- pyrazoline als cyclooxygenase-2 inhibitoren | |
| ATE209199T1 (de) | Chinolin und chinazolin derivate zur behandlung von arthritis | |
| ATE159514T1 (de) | Substituierte aminsäure derivate verwendbar für die behandlung von arteriosclerosis | |
| MY128323A (en) | Thiazole derivatives for inhibition of cytokine production and of cell adhesion | |
| NO913566L (no) | Aryl-kondenserte- og hetaryl-kondenserte-2,4-diazepin-og-2,4-diazocinforbindelser og fremgangsmaate for deres fremstilling. | |
| DE69636048D1 (de) | Piperazin- und Homopiperazinderivate zur Hemmung der Zellenadhäsion und Zelleninfiltration | |
| ES8801545A1 (es) | Un procedimiento para la preparacion de compuestos aminoheterociclicos | |
| AU539177B2 (en) | Amino alkoxy pyrazoles | |
| DE69629133D1 (de) | Substituierte Aminochinazolinon (thion) Derivate | |
| ATE502030T1 (de) | Imidazolderivate, verfahren zu deren herstellung und deren verwendung | |
| ATE241976T1 (de) | N,n'-bis (sulfonyl) hydrazine die als antineoplastische mittel nützlich sind | |
| DE69827706D1 (de) | 5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems | |
| EA200100155A2 (ru) | Новые производные 6-амино или 6-гидразиносульфонил-3-хинолинилфосфоновой кислоты, способ их получения и содержащие их фармацевтические композиции | |
| DE69626846D1 (de) | Phosphonsäurederivate mit metallopeptidase inhibierender aktivität | |
| ATE212842T1 (de) | Quinoxalin-derivate zur behandlung von tinnitus | |
| ATE223406T1 (de) | 1,4-disubstitutierte cyclohexanderivate zur behandlung von depression |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |